Navigation Links
MiddleBrook Pharmaceuticals Reports Third Quarter 2008 Financial Results
Date:11/13/2008

he Nine Months

Ended September 30, Ended September 30,

2008 2007 2008 2007

Product sales $2,267 $3,145 $7,183 $7,598

Costs and expenses:

Cost of product sales 350 1,184 1,345 1,865

Research and development 6,898 5,509 14,270 18,485

Selling, general and

administrative 7,004 6,476 15,695 20,474

Total expenses 14,252 13,169 31,310 40,824

Loss from operations (11,985) (10,024) (24,127) (33,226)

Interest income 172 126 387 482

Interest expense - (159) - (529)

Change in fair value

of warrants (954) - (6,714) -

Other income (expense) - - - 75

Loss including

noncontrolling interest (12,767) (10,057) (30,454) (33,198)

Loss (gain) attributable

to noncontrolling

interest 305 - 485 -

Net loss $(12,462) $(10,057) $(29,969) $(33,198)

Basic and diluted net

loss per share

applicable to common

stockholders $(0.19) $(0.22) $(0.52) $(0.78)

Shares used in

calculation of basic

and diluted net loss

per share 64,649 46,651 58,021 42,832

MiddleBrook Pharmaceuticals, Inc.

Condensed Consolidated Balance Sheets

(Amounts in thousands, except per share amounts)

September 30, December 31,


'/>"/>

SOURCE MiddleBrook Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. MiddleBrook Pharmaceuticals Raises Up to $10 Million from Deerfield Management
2. MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results
3. MiddleBrook Pharmaceuticals to Raise $21 Million Through Private Placement of Common Equity
4. MiddleBrook Pharmaceuticals Engages Morgan Stanley in Its Strategic Process
5. MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results
6. MiddleBrook Pharmaceuticals Reports Second Quarter 2008 Results
7. MiddleBrook to Webcast Management Presentation at the 10th Annual Rodman & Renshaw Healthcare Conference
8. MiddleBrook Pharmaceuticals Schedules Conference Call and Webcast for Third Quarter 2008 Financial Results
9. MiddleBrook Pharmaceuticals Retains National Account Firm VCG & Associates
10. MiddleBrook Pharmaceuticals Announces Orange Book Listing of Moxatag(TM) Patents
11. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... New York (PRWEB) May 21, 2013 ... Wright Conserve hip replacement lawsuits in U.S. ... Order in response to a request from Plaintiffs’ Counsel ... the Defendant. The May 17th Order grants that ... may be conducted. (In re: Wright Medical Technology, Inc., ...
(Date:5/21/2013)... 21, 2013 The In View ... networks and cable channels across the country, announces it ... YouTube channel. The producers of the series proudly bring ... shipping industry, the manufacturing industry, health-related companies, medical facilities ... and medical practitioners in all parts of the United ...
(Date:5/21/2013)... Phoseon Technology will present their advanced UV ... European Ink Jet Conference (June 5-6, Barcelona, Spain). ... invest in product development to enable breakthrough capability and ... in printing applications. Phoseon currently has a wide ... air cooled and water cooled solutions to match the ...
(Date:5/21/2013)... Diversity Focus, a non-profit organization striving to improve the ... Creative Corridor region, is releasing results for its 2013 ... Thursday, May 23rd at 10:30 a.m. The survey ... , The survey is a critical component to the ... nurture and retain people of diverse backgrounds, cultures and ...
(Date:5/21/2013)... 2013 Global Proving Ground (GPG), a ... largest online retailer of health and fitness supplements, are ... show, Warrior Island. “We cast the show by ... Twitter, with our unique social networking platform,” states show’s ... fighters on an island in the Pacific Ocean, where ...
Breaking Medicine News(10 mins):Health News:Wright Hip Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order in Federal Wright Conserve Hip Replacement Litigation 2Health News:Wright Hip Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order in Federal Wright Conserve Hip Replacement Litigation 3Health News:In View hosted by Larry King Announces New Videos on its YouTube Channel 2Health News:Diversity Focus Announces Results from 2013 Creative Corridor Survey at News Conference on Thursday, May 23rd at 10:30 a.m. 2Health News:Bodybuilding.com Partners with Global Proving Ground’s New Reality Show Warrior Island 2Health News:Bodybuilding.com Partners with Global Proving Ground’s New Reality Show Warrior Island 3
... out of the pan into the fire itself, the burning ... Government directives to disclose levels of trans fats in packaged ... of trans fat in french fries.// The tests have put ... third more ( 8 grammes as against earlier 6 grams ...
... flu has been reported from a chicken farm located in ... // monitored and is believed to be under control, according ... than 15, 000 chickens in a farm (Yijing township), confirmed ... response to the above situation, a special team to combat ...
... blood pressure clinical trial is launching a nationwide outreach ... pressure. // This is a follow-up to the Antihypertensive ... and is being launched in collaboration with the National ... ,The ALLHAT blood pressure study had compared the effectiveness ...
... people who suffer from the Ischemic Heart Disease (IHD) which ... // person to person, depending upon whether it is ... is affected by this medical condition, and where Western countries ... ,When patients seek medical care for chest pain, diagnosticians ...
... M to Kenya by the World Bank for HIV/AIDS education ... as it has been delayed due to some allegations pertaining ... are against the Kenyan government, the SAPA/Mail & Guardian reports ... Ministry of Health in February 2005 it had failed to ...
... the February issue of the Journal of Periodontology, says ... developing preeclampsia in pregnancy. // The results of the ... weight babies as compared to women who do not ... more prevalent in the preeclamptic group by almost 64 ...
Cached Medicine News:Health News:Diuretics More Effective In Controlling High Blood Pressure 2Health News:Gum Disease Associated With Increased Risk of Preeclampsia 2
(Date:5/21/2013)... 2013 New data released today at ... show that the NeuroStar TMS Therapy System ® ... remission in patients with Major Depressive Disorder (MDD) ... maintained through one year of treatment.  At the ... achieved symptomatic improvement while 41 percent reported complete ...
(Date:5/21/2013)... May 21, 2013 Valeant ... VRX ) (TSX: VRX) today announced ... at its 2013 annual meeting of ... the vote for the election of ... H. Farmer235,731,9341,964,748Robert A. Ingram233,865,8763,830,806Theo Melas-Kyriazi237,081,508615,174G. Mason ...
(Date:5/21/2013)... May 21, 2013  Lakeland Industries, Inc. (NASDAQ: ... of industrial protective clothing for industry, municipalities, healthcare ... local levels, today announced that the Company accepted ... Senior Credit Facility subject to certain terms and ... financing.  However, no assurances can be given that ...
Breaking Medicine Technology:New Data Show Long-Term Benefit of Transcranial Magnetic Stimulation in Difficult-to-Treat Patients with Depression using NeuroStar TMS Therapy System 2New Data Show Long-Term Benefit of Transcranial Magnetic Stimulation in Difficult-to-Treat Patients with Depression using NeuroStar TMS Therapy System 3New Data Show Long-Term Benefit of Transcranial Magnetic Stimulation in Difficult-to-Treat Patients with Depression using NeuroStar TMS Therapy System 4Valeant Pharmaceuticals Announces 2013 Annual Meeting Results 2Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 2Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 3Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 4Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 5Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 6Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 7Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 8Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 9Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 10Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 11Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 12Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 13
... DETROIT, March 22, 2011 The Detroit Medical ... healthcare provider in Michigan to offer a new ... heartbeat) in patients who struggle with this potentially ... state-of-the-art technology – known formally as the "Arctic ...
... ReGen Biologics, Inc. (ReGen), manufacturer of the popular and ... and Drug Administration,s (FDA) offer of a hearing under 21 ... rescind clearance of the device. According to ReGen ... experience with the FDA over the past six years makes ...
Cached Medicine Technology:Detroit Medical Center Is First in Michigan to Offer New Breakthrough Technology for Correcting Irregular Heartbeat 2Detroit Medical Center Is First in Michigan to Offer New Breakthrough Technology for Correcting Irregular Heartbeat 3Detroit Medical Center Is First in Michigan to Offer New Breakthrough Technology for Correcting Irregular Heartbeat 4ReGen to FDA: 'Thanks, But No Thanks' 2ReGen to FDA: 'Thanks, But No Thanks' 3ReGen to FDA: 'Thanks, But No Thanks' 4
... Platinum is a compact and quiet, ... at 120 psi/8 bar, it provides ... size with noticeable noise reduction. A ... with an enhanced ergonomic handpiece to ...
Relocatable frame has been designed specifically for fractionated stereotactic radiotherapy treatments. It provides a fast, non-invasive and reproducible fixation of the patient....
... Leksell Stereotactic System is the ... the world. Reliability, flexibility, versatility ... features of the Leksell Stereotactic ... on the center-of-arc principle and ...
Table-mounted, retraction for radiolucent anterior spine procedures. Fully-adjustable for any approach and any patient. Combine with our radiolucent blade kit for optimal visibility....
Medicine Products: